References
1. L.F. Prescott and W.S. Nimmo, Novel Drug Delivery and Its Therapeutic Application, F.L. Prescott, Ed. (John Wiley and Sons, Oxford, UK, 1989), pp. 1–11.
2. Y.W. Chien, "Controlled and Modulated-Release Drug Delivery Systems," in Encyclopedia of Pharmaceutical Technology, J. Swarbrick and J.C. Boylan, Eds. (Marcel Dekker, New York, 1990), p. 280.
3. G. Chawla et al., Pharm. Technol.
27 (7), 50–68 (2003).
4. Medicines Complete, "Ibuprofen/Indomethacin,"
http://www.medicinescomplete.com/mc/martindale/current, accessed Dec. 19, 2006.
5. J.C. Valle-Jones, J. Smith, and D. Rowely-Jones, Br. J. Clin. Pract.
38 (7), 353–358 (1984).
6. T.H. Kantor, Ann. Intern. Med.
91 (6), 877–882 (1979).
7. A. Avgerinos and S. Malamataris, Int. J. Pharm.
63 (1), 77–80 (1990).
8. N. Sarkar et al., Curr. Ther. Res. Clin. Exp.
44 (6), 11–21 (1988).
9. M. Galeon et al., Curr. Ther. Res. Clin. Exp.
29 (4), 217–234 (1981).
10. S. Bolton and Charles Bon, "Factorial Designs," in Pharmaceutical Statistics: Practical and Clinical Applications, J. Swarbrick, Ed. (Marcel Dekker, New York, 3rd ed., 1984), pp. 265–285.
11. N.A. Armstrong and K.C. James, "Factorial Designs of Experiments," in Understanding Experimental Design and Interpretation in Pharmaceutics, (Ellis Harwood, London, 1990), pp. 27–54.
12. R. Ziyaur, A. Mushir, and R.K. Khar, Acta Pharm.
56 (2), 49–57 (2006).
13. N. Tomoya et al., Chem. Pharm. Bull.
54 (6), 14–51 (2006).
14. B.S. Dave, A.F. Amin, and M.M. Patel, AAPS PharmSciTech
5 (2), 45–49 (2004).
15. USP 27–NF 22 (USP, Rockville, MD, 2003), pp. 953–955.
16. M. Rosa, H. Zia, and T. Rhodes, Int. J. Pharm.
105 (34), 65–70 (1994).
17. G.S. Banker and N.R. Anderson, "Tablets," in The Theory and Practice of Industrial Pharmacy, L. Lachmann, H.A. Liberman, and J.L. Kaing, Eds. (Varghese Publishing House, Mumbai, 3rd ed., 1987), pp. 295–299.
18. "Tablets" (Indian Pharmacopoeia, (Controller of Publication, Delhi, India, Vol. II, 1996), pp. 734–736.
19. J. Castellanos, M.R.H. Zia, and C.T. Rhodes, Int. J. Pharm.
105 (34), (Apr25), 65–70 (1994).
20. J.E. Devereux, J.M. Newton, and M.B. Short, J. Pharm. Pharmacol.
42 (8), 500–501 (1990).
21. V.S. Chitnis, V.S. Malshe, and J.K. Lalla, Drug Dev. Ind. Pharm.
17 (10), 879–892 (1991).
22. G.M. Khan, Sciences
1 (8), 350–354 (2001).
23. D.M. Morkhade, Indian J. Pharm. Sci.
68 (3), 53–58 (2006).
24. T. Higuchi, J. Pharm. Sci.
52 (12), 1145–1149 (1963).
25. N.A. Peppas and J.J. Sahlin, Int. J. Pharm.
57 (1), 169–172 (1989).
|
